Parallel Advisors’s Standard BioTools LAB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $44 | Hold |
37
| – | – | ﹤0.01% | 3471 |
|
|
2025
Q1 | $40 | Hold |
37
| – | – | ﹤0.01% | 3456 |
|
|
2024
Q4 | $65 | Hold |
37
| – | – | ﹤0.01% | 3445 |
|
|
2024
Q3 | $71 | Hold |
37
| – | – | ﹤0.01% | 3330 |
|
|
2024
Q2 | $65 | Sell |
37
-5,953
| -99% | -$10.5K | ﹤0.01% | 3247 |
|
|
2024
Q1 | $16.2K | Buy |
+5,990
| New | +$16.2K | ﹤0.01% | 2092 |
|
|
2022
Q2 | – | Sell |
-6,895
| Closed | -$26K | – | 3179 |
|
|
2022
Q1 | $26K | Hold |
6,895
| – | – | ﹤0.01% | 1590 |
|
|
2021
Q4 | $27K | Hold |
6,895
| – | – | ﹤0.01% | 1629 |
|
|
2021
Q3 | $45K | Hold |
6,895
| – | – | ﹤0.01% | 1307 |
|
|
2021
Q2 | $42K | Hold |
6,895
| – | – | ﹤0.01% | 1309 |
|
|
2021
Q1 | $31K | Hold |
6,895
| – | – | ﹤0.01% | 1379 |
|
|
2020
Q4 | $41K | Hold |
6,895
| – | – | ﹤0.01% | 1168 |
|
|
2020
Q3 | $51K | Sell |
6,895
-3,676
| -35% | -$27.2K | ﹤0.01% | 1044 |
|
|
2020
Q2 | $42K | Hold |
10,571
| – | – | ﹤0.01% | 1109 |
|
|
2020
Q1 | $26K | Buy |
+10,571
| New | +$26K | ﹤0.01% | 1191 |
|
|
2019
Q4 | – | Sell |
-1,727
| Closed | -$8K | – | 2451 |
|
|
2019
Q3 | $8K | Buy |
1,727
+651
| +61% | +$3.02K | ﹤0.01% | 1747 |
|
|
2019
Q2 | $13K | Buy |
+1,076
| New | +$13K | ﹤0.01% | 1457 |
|